"They pulled that funding away and we're not recovering. it's getting worse": deaths of despair in post-austerity north east England von Price, Timothy

Volltext

Colorectal cancer:Metastases to a single organ von Vatandoust, Sina, Price, Timothy J, Karapetis, Christos S

Volltext

Management of gastric cancer in Asia: resource-stratified guidelines von Shen, Lin, Prof, Shan, Yan-Shen, Prof, Hu, Huang-Ming, MD, Price, Timothy J, Prof, Sirohi, Bhawna, DCH, Yeh, Kun-Huei, Prof, Yang, Yi-Hsin, PhD, Sano, Takeshi, MD, Yang, Han-Kwang, Prof, Zhang, Xiaotian, MD, Park, Sook Ryun, MD, Fujii, Masashi, Prof, Kang, Yoon-Koo, Prof, Chen, Li-Tzong, Prof

Volltext

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-infer... von Price, Timothy J, Dr, Peeters, Marc, Prof, Kim, Tae Won, MD, Li, Jin, MD, Cascinu, Stefano, MD, Ruff, Paul, MBBCh, Suresh, Atilli Satya, MD, Thomas, Anne, PhD, Tjulandin, Sergei, MD, Zhang, Kathy, PhD, Murugappan, Swaminathan, MD, Sidhu, Roger, MD

Volltext

Insights From the IDEA Collaboration: Are They Enough? von Smith, Annabel, Geerinckx, Barbara, Price, Timothy J

Volltext

Role of Aquaporin 1 Signalling in Cancer Development and Progression von Tomita, Yoko, Dorward, Hilary, Yool, Andrea J, Smith, Eric, Townsend, Amanda R, Price, Timothy J, Hardingham, Jennifer E

Volltext

Anti-Angiogenic Properties of Ginsenoside Rg3 von Nakhjavani, Maryam, Smith, Eric, Townsend, Amanda R., Price, Timothy J., Hardingham, Jennifer E.

Volltext

Sotorasib for Lung Cancers with KRAS p.G12C Mutation von Skoulidis, Ferdinandos, Li, Bob T, Dy, Grace K, Price, Timothy J, Falchook, Gerald S, Wolf, Jürgen, Italiano, Antoine, Schuler, Martin, Borghaei, Hossein, Barlesi, Fabrice, Kato, Terufumi, Curioni-Fontecedro, Alessandra, Sacher, Adrian, Spira, Alexander, Ramalingam, Suresh S, Takahashi, Toshiaki, Besse, Benjamin, Anderson, Abraham, Ang, Agnes, Tran, Qui, Mather, Omar, Henary, Haby, Ngarmchamnanrith, Gataree, Friberg, Gregory, Velcheti, Vamsidhar, Govindan, Ramaswamy

Volltext

Momentum and Turbulent Transport in Sparse, Organized Vegetative Canopies von Torkelson, Gregory, Price, Timothy A., Stoll, Rob

Volltext

Modified XELIRI (capecitabine plus irinotecan) for metastatic colorectal cancer von Price, Timothy J

Volltext

Advanced colorectal cancer treatment options beyond standard systemic therapy von Price, Timothy J

Volltext

Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress von Hardingham, Jennifer E, Grover, Phulwinder, Winter, Marnie, Hewett, Peter J, Price, Timothy J, Thierry, Benjamin

Volltext

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity von Canon, Jude, Rex, Karen, Saiki, Anne Y., Mohr, Christopher, Cooke, Keegan, Bagal, Dhanashri, Gaida, Kevin, Holt, Tyler, Knutson, Charles G., Koppada, Neelima, Lanman, Brian A., Werner, Jonathan, Rapaport, Aaron S., San Miguel, Tisha, Ortiz, Roberto, Osgood, Tao, Sun, Ji-Rong, Zhu, Xiaochun, McCarter, John D., Volak, Laurie P., Houk, Brett E., Fakih, Marwan G., O’Neil, Bert H., Price, Timothy J., Falchook, Gerald S., Desai, Jayesh, Kuo, James, Govindan, Ramaswamy, Hong, David S., Ouyang, Wenjun, Henary, Haby, Arvedson, Tara, Cee, Victor J., Lipford, J. Russell

Volltext

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer von Van Cutsem, Eric, Bang, Yung-Jue, Feng-yi, Feng, Xu, Jian M., Lee, Keun-Wook, Jiao, Shun-Chang, Chong, Jorge León, López-Sanchez, Roberto I., Price, Timothy, Gladkov, Oleg, Stoss, Oliver, Hill, Julie, Ng, Vivian, Lehle, Michaela, Thomas, Marlene, Kiermaier, Astrid, Rüschoff, Josef

Volltext

Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study von Bedrikovetski, Sergei, Traeger, Luke, Price, Timothy J., Carruthers, Scott, Selva‐Nayagam, Sudarshan, Moore, James W., Sammour, Tarik

Volltext

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies von Tie, Jeanne, Cohen, Joshua D., Lo, Serigne N., Wang, Yuxuan, Li, Lu, Christie, Michael, Lee, Margaret, Wong, Rachel, Kosmider, Suzanne, Skinner, Iain, Wong, Hui Li, Lee, Belinda, Burge, Matthew E., Yip, Desmond, Karapetis, Christos S., Price, Timothy J., Tebbutt, Niall C., Haydon, Andrew M., Ptak, Janine, Schaeffer, Mary J., Silliman, Natalie, Dobbyn, Lisa, Popoli, Maria, Tomasetti, Cristian, Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Gibbs, Peter

Volltext

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic C... von PEETERS, Marc, JAY PRICE, Timothy, STRICKLAND, Andrew H, WILSON, Gregory, CIULEANU, Tudor-Eliade, ROMAN, Laslo, VAN CUTSEM, Eric, TZEKOVA, Valentina, COLLINS, Simon, OLINER, Kelly S, RONG, Alan, GANSERT, Jennifer, CERVANTES, Andrés, SOBRERO, Alberto F, DUCREUX, Michel, HOTKO, Yevhen, ANDRE, Thierry, CHAN, Emily, LORDICK, Florian, PUNT, Cornelis J. A

Volltext

Biologic therapies in the metastatic colorectal cancer treatment continuum – Applying current evidence to clinical practice von Peeters, Marc, Price, Timothy

Volltext

Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? von Price, Timothy J., Beeke, Carol, Ullah, Shahid, Padbury, Robert, Maddern, Guy, Roder, David, Townsend, Amanda R., Moore, James, Roy, Amitesh, Tomita, Yoko, Karapetis, Christos

Volltext

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer von HALLER, Daniel G, TABERNERO, Josep, MAROUN, Jean, DE BRAUD, Filippo, PRICE, Timothy, VAN CUTSEM, Eric, HILL, Mark, GILBERG, Frank, RITTWEGER, Karen, SCHMOLL, Hans-Joachim

Volltext